Given the current evidence of microglial dysfunction in neurodegeneration, we speculate that changes in brain TGF-β signaling in AD could alter microglial state and trigger their pathogenic functions (Salter and Stevens, 2017). Here, TGFB1 is linked to Alzheimer disease.